Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers
Clinical trial NCT04667624 · COMPLETED
Trial details
- NCT number
- NCT04667624
- Sponsor
- Hanlim Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-29
- Primary completion
- 2020-04-28
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.